Standard Biotools (LAB) Cash & Equivalents (2010 - 2026)
Standard Biotools (LAB) posted quarterly Cash & Equivalents of $265.8 million for Q1 2026, up 73.17% year-over-year from $153.5 million in Q1 2025, and up 119.9% quarter-over-quarter from $120.9 million in Q4 2025.
Standard Biotools (LAB) Cash & Equivalents (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Cash & Equivalents for 17 consecutive years, with $265.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Equivalents rose 73.17% year-over-year to $265.8 million; the TTM figure through Mar 2026 stood at $265.8 million (up 73.17% YoY), while the FY2025 annual figure was $120.9 million, down 28.41% from the prior year.
- Cash & Equivalents climbed to $265.8 million in Q1 2026 per LAB's latest filing, from $120.9 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $288.3 million in Q1 2024 and bottomed at $31.0 million in Q1 2022.
- Historically, Cash & Equivalents has averaged $141.7 million across 5 years, with a median of $129.4 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 7319.0% — and 2025, when it sank 46.78%.
- Standard Biotools' Cash & Equivalents stood at $82.3 million in 2022, then slumped by 36.23% to $52.5 million in 2023, then soared by 221.56% to $168.8 million in 2024, then decreased by 28.41% to $120.9 million in 2025, then surged by 119.9% to $265.8 million in 2026.
- Business Quant data shows LAB's Cash & Equivalents at $265.8 million in Q1 2026, $120.9 million in Q4 2025, and $129.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Standard Biotools | 260.01 Mn | -216.70 Mn | 10.54 Mn | 270.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270.03 Mn |
| Mar 31, 2026 | 265.77 Mn |
| Dec 31, 2025 | 120.86 Mn |
| Sep 30, 2025 | 129.42 Mn |
| Jun 30, 2025 | 158.62 Mn |
| Mar 31, 2025 | 153.47 Mn |
| Dec 31, 2024 | 168.82 Mn |
| Sep 30, 2024 | 211.94 Mn |
| Jun 30, 2024 | 271.10 Mn |
| Mar 31, 2024 | 288.34 Mn |
| Dec 31, 2023 | 52.50 Mn |
| Sep 30, 2023 | 80.45 Mn |
| Jun 30, 2023 | 143.10 Mn |
| Mar 31, 2023 | 114.46 Mn |
| Dec 31, 2022 | 82.32 Mn |
| Sep 30, 2022 | 61.22 Mn |
| Jun 30, 2022 | 75.38 Mn |
| Mar 31, 2022 | 31.00 Mn |
| Dec 31, 2021 | 29.47 Mn |
| Sep 30, 2021 | 30.33 Mn |